April 27, 2022

Les Rendez-vous Audace

Les Rendez-vous Audace

Since 2014, IRIC has been organizing the Audacious benefit event, which annually contributes to funding breakthroughs in the fight against cancer. For a second year, the Institute is offering you a virtual formula that is just as promising, with a view to democratizing science.

In 2022, les Rendez-vous Audace provide you with an opportunity to attend inspiring and genuinely audacious discussions revolving around a mobilizing theme:  A world in change, a next generation in action.

Three next generation stakeholders – a young patient, a medical oncologist and an IRIC Principal Investigator – will address cancer in its social, human and scientific dimensions. Inspired and inspiring, these women will share the resilience, hope and innovation that are at the very heart of their actions.

This conference is offered in french.

 

Online donation

 

Sponsorship opportunities

Download and complete the confirmation form

 

*For any request for information or to obtain a personalized sponsorship, please contact Steve Ntambwe, Senior Development Advisor: (514 343-7770, 27938) or by email: steve.ntambwe@umontreal.ca

A world in change, a next generation in action

In the form of scientific and human discussions, the event will be led by André Robitaille, actor and host, who will have the privilege of speaking with Judith Lafaille, patient and ambassador, Eralda Kina, oncologist and Ph.D. student at IRIC, as well as Geneviève Deblois, Principal Investigator at IRIC and Assistant Professor in the Faculty of Pharmacy of the Université de Montréal.

A rich and dynamic event that you don’t want to miss! Register now.

 

LOG IN: April 27 starting at 11:30 AM

 

Since its creation, the Institute has taken charge of changing the landscape of cancer research and acts as a leader in the training of emerging researchers, the genesis of new knowledge and the discovery of therapies. To achieve different results – to better understand, seek, find and treat cancer – IRIC is forging its own path.

Thank you to our sponsors!